Medlife and PharmEasy have applied to the Competition Commission of India (CCI) to formally approve the proposed merger
Snapdeal had claimed that its order volumes had grown significantly since May 18 when ecommerce was allowed to sell non-essentials across the country except in containment zones
Comments
Post a Comment